IA
GILD icon

Inspire Advisors’s Gilead Sciences GILD Stock Holding History

Inspire Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Sell
2,149
-191
-8% -$25.2K 0.02% 574
2026
Q1 		$326K Buy
+2,340
New +$328K 0.03% 437

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Inspire Advisors's GILD Position: Q2 2026 in Review

Inspire Advisors reduced its Gilead Sciences (GILD) stake by 8.2% in Q2 2026, selling an estimated $25.2K and leaving 2,149 shares worth $272K. The position accounts for 0.02% of the portfolio, ranked #574.

Inspire Advisors first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $326K in Q1 2026. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Inspire Advisors held 2,149 shares of Gilead Sciences worth $272K as of Q2 2026.
  • Inspire Advisors sold 191 Gilead Sciences shares in Q2 2026, an estimated $25.2K.
  • Gilead Sciences made up 0.02% of Inspire Advisors's portfolio in Q2 2026, its #574 holding.
  • Inspire Advisors first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • Inspire Advisors's Gilead Sciences position peaked at $326K in Q1 2026.
  • 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.